Taking on analysts’ expectations and winning: Neogenomics Inc (NEO)
With 3.11 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.03 million shares. The 52-week range on NEO shows that it touched its highest point at $19.11 and its lowest point at $6.08 during that stretch. It currently has a 1-year price target of $10.62. Beta for […]
Are Smart Investors Making the Right Decision? Neogenomics Inc (NEO)
With 13.17 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.68 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $9.93 whereas the lowest price it dropped to was $6.4. The 52-week range on […]
A look into Neogenomics Inc (NEO)’s deeper side
With 2.04 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.46 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $10.14 whereas the lowest price it dropped to was $9.81. The 52-week range on […]
A better buy-in window may exist right now for Neogenomics Inc (NEO)
With 2.09 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.46 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $10.18 whereas the lowest price it dropped to was $9.3706. The 52-week range on […]
Neogenomics Inc (NEO) Clearly Signals Buy-Into the Stock: Don’t ignore the signals
With 2.07 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.35 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $9.14 whereas the lowest price it dropped to was $8.27. The 52-week range on […]
Are Smart Investors Making the Right Decision? Neogenomics Inc (NEO)
With 2.53 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.18 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $10.0699 whereas the lowest price it dropped to was $9.57. The 52-week range on […]
Neogenomics Inc (NEO) can make a big difference with a little luck
With 1.18 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.19 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $9.98 whereas the lowest price it dropped to was $9.6. The 52-week range on […]
Is Neogenomics Inc (NEO) positioned for future growth?
With 1.97 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.13 million shares. The 52-week range on NEO shows that it touched its highest point at $19.11 and its lowest point at $8.98 during that stretch. It currently has a 1-year price target of $18.67. Beta for […]
Neogenomics Inc (NEO) Clearly Signals Buy-Into the Stock: Don’t ignore the signals
With 1.07 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.02 million shares. The 52-week range on NEO shows that it touched its highest point at $19.11 and its lowest point at $9.59 during that stretch. It currently has a 1-year price target of $18.67. Beta for […]
